TCL Archive In Brief: Charles Heidelberger, Sol Spiegelman Both Die of Cancer; Robert Wittes New CTEP Director January 28, 1983
TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009